(±)-nabilone

URI: https://gptkb.org/entity/(±)-nabilone
GPTKB entity
Statements (32)
Predicate Object
gptkbp:instanceOf gptkb:drug
synthetic cannabinoid
gptkbp:approvedBy gptkb:FDA
1985
gptkbp:ATCCode gptkb:A04AD11
gptkbp:CASNumber gptkb:51022-71-6
gptkbp:chemicalFormula C24H36O3
gptkbp:contraindication hypersensitivity to cannabinoids
gptkbp:developedBy 1970s
gptkbp:eliminationHalfLife 2 hours
gptkbp:excretion gptkb:kidney
https://www.w3.org/2000/01/rdf-schema#label (±)-nabilone
gptkbp:IUPACName (±)-[6aS-trans]-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one
gptkbp:legalStatus gptkb:Schedule_II_controlled_substance
gptkbp:marketedAs gptkb:Cesamet
gptkbp:mechanismOfAction cannabinoid receptor agonist
gptkbp:meltingPoint 145–146 °C
gptkbp:metabolism liver
gptkbp:pregnancyCategory C
gptkbp:PubChem_CID 21616
gptkbp:relatedTo gptkb:dronabinol
gptkb:THC
gptkbp:routeOfAdministration oral
gptkbp:sideEffect dizziness
drowsiness
euphoria
hallucinations
dry mouth
gptkbp:UNII gptkb:6M3C89ZY6R
gptkbp:usedFor treatment of chemotherapy-induced nausea and vomiting
gptkbp:bfsParent gptkb:nabilone
gptkbp:bfsLayer 7